Elevated serum IgE and peripheral eosinophilia may predict risk of flare after treatment, while a dominant eosinophilic infiltrate is not common in IgG4-RD involved organ23. The gene discussed is IGHE; the disease is immunoglobulin G4-related sclerosing disease.